Track topics on Twitter Track topics that are important to you
An initial public offering of 0.93 million shares was priced by Salt Lake City-based ProLung in hopes of raising $7 million. -More-
DGAP-News: Epigenomics AG / Key word(s): Product Launch 19.12.2017 / 08:45 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG gets CE-IVD M...
European regulators gave Epigenomics CE-IVD marking for its Epi proLung, a blood-based test that detects lung cancer by spott -More-
This open label clinical study will be conducted in School of Chinese Medicine Clinics at The University of Hong Kong (HKU) to preliminarily determine whether treatment with the herbal for...
We have published hundreds of ProLung news stories on BioPortfolio along with dozens of ProLung Clinical Trials and PubMed Articles about ProLung for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ProLung Companies in our database. You can also find out about relevant ProLung Drugs and Medications on this site too.